Le PSA libre

Progres en Urologie

Volumn 7, Issue 1, 1997, Pages 88-91

  Ravery, Vincent ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

BLOOD; CHEMISTRY; HUMAN; MALE; METABOLISM; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROTEIN BINDING; REVIEW;

ALPHA 1-ANTICHYMOTRYPSIN; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN BINDING;

EID: 0031065592     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ABRAHAMSSON P.A., LILJA H Free and complex forms of prostate specific antigen in serum. Tumour Marker Update, 1994, 6, 1-4.
2. BANGMA C.H., KRANSE R., BUJENBERG B.G., SCHRÖDER F.H. The value of screening test in the detection of prostate cancer. Part I : Results of a retrospective evaluation of 1726 men. Urology. 1995, 46, 773-778.
3. BANGMA C.H., KRANSE R., BLUENBERG B.G., SCHRÖDER F.H. The value of screening test in the detection of prostate cancer. Part II : Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Urology, 1995, 46, 779-784.
4. CATALONA W J., SMITH D.S, WOLFER R.L. et al. Evaluation of percentage of free serum prostate-specific antigene to improve specificity of prostate cancer screening. J.A.M A., 1995, 274, 1214-1220.
5. CHAUTARD D., DAVER A., BAU B. et al. Evaluation clinique de la mesure de l'Antigène Spécifique de Prostate (PSA) sous sa forme libre sérique. Prog. Urol. 1996, 6, 368-373.
6. CHEN Y.T., LUDERER A.A., THIEL R P., CARLSON G, CUNY C.L., SORIANO T.F Using proportions of free to tolal prostate-specific antigen, age. and total prostate-specific antigen to predict the probability of prostate cancer Urology, 1996, 47, 518-524.
7. CHRISTENSSON A., BJÖRK T., NILSSON O. Serum prostate specific antigen complexed to αl-antichymotrypsin as an indicator of prostate cancer. J. Urol., 1993, 150, 100-105.
8. DEMURA T., SHINOHARA N., TANAKA M. et al. The proportion of free to total prostate specific antigen. A method of detecting prostate carcinoma. Cancer, 1996, 77, 1137-1143.
9. FROSCHERMAIER S.E., PILARSKY C.P., WIRTH M.P. Clinical significance of the determination of non complexed prostate-specific antigen as a marker for prostate carcinoma Urology, 1996, 47, 525-528.
10. HAAB F. MEULEMANS A., BOCCON-GIBOD LI., DAUGE M.C., DELMAS V., BOCCON-GIBOD L. Clearance of serum PSA after open surgery for Benign Prostatic Hypertrophy. Radical cystectomy and radical prostatectomy. The prostate, 1995, 26, 334-338.
11. HUBER P.R., MATTARELLI G., STRITTMATTER B., VAN STEENBRUGGE G.J., SCHMID H.P., MAURER A. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-antichymotrypsin. The Prostate, 1995, 27, 166-175.
12. LILJA H., COCKETT A.T.K., ABRAHAMSSON P.A. Prostate specific antigen predominantly forms a complex with alpha-1-abntichymotrypsin in blood. Cancer, 1992, 70, 230-234.
13. LILJA H. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer Scand. J. Clin. Lab. Invest., 1995, 55, 47-56.
14. LUDERER A.A., CHEN Y.T., SORIANO T.F. et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 1995, 46, 187-194.
15. MEULEMANS A., RAVERY V., BOCCON-GIBOD L.I., DELMAS V., BOCCON-GIBOD L. Clearance of free serum PSA after open surgery for benign prostatic hypertrophy/radical prostatectomy and evaluation of free serum PSA in patients with postoperative biological recurrence. Xllth Congress of the EAU, 1-4/09/96.
16. OESTERLING J.E., JACOBSEN S.J., KLEE G.G. et al. Free complexed and total serum prostate specific antigen : the establishment of appropriate reference ranges for their concentrations and ratios. J. Urol., 1995, 154, 1090-1095.
17. PAPSIDERO L.D., WANG M.C., VALENZUELA L.A., MURPHY O.P., CHU T.M. A prostate specific antigen in sera of prostatic cancer patients. Cancer Res., 1980, 40, 2428-2832.
18. PRESTIGIACOMO A, STAMEY T., LILJA H., PETTERSSON K., WOLFERT B. Comparison of patients with benign prostatic hyperplasia (BPH) and prostate cancer (CaP) by measuring non-complexed «free» prostate specific antigen (PSA) : The «best case» scenario. J. Urol., 1995, 153, 462A.
19. STENMAN U.K., LEINONEN J, ALFTAHAN H., RANNIKKO S., TUHKANEN K., ALFTHAN O. A complex between prostate specific antigen and alpha-1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer : assay of the complex improves clinical sensitivity for cancer. Cancer Res., 1991, 51, 222-226.